Partner Investment Management’s Coherus Oncology CHRS Stock Holding History

Partner Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$68K	Sell	3,771 -4,035	-52%	-$74.4K	0.49%	39
2019 Q3	$158K	Sell	7,806 -4,801	-38%	-$95.9K	0.27%	59
2019 Q2	$279K	Buy	12,607 +4,493	+55%	+$78K	0.3%	65
2019 Q1	$111K	Buy	+8,114	New	+$108K	0.13%	81
2017 Q3	–	Sell	-24,236	Closed	-$348K	–	90
2017 Q2	$348K	Buy	24,236 +8,027	+50%	+$154K	0.47%	60
2017 Q1	$343K	Buy	+16,209	New	+$399K	0.42%	69
2016 Q1	–	Sell	-3,966	Closed	-$91K	–	81
2015 Q4	$91K	Sell	3,966 -3,065	-44%	-$78.9K	0.15%	60
2015 Q3	$141K	Hold	7,031	–	–	0.21%	58
2015 Q2	$203K	Buy	+7,031	New	+$178K	0.29%	67

Other funds holding CHRS

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Partner Investment Management's CHRS Position: Q4 2019 in Review

Partner Investment Management reduced its Coherus Oncology (CHRS) stake by 52% in Q4 2019, selling an estimated $74.4K and leaving 3,771 shares worth $68K. The position accounts for 0.49% of the portfolio, ranked #39.

Partner Investment Management first reported a position in CHRS in Q2 2015 and has held it in 9 quarters since. The position peaked at $348K in Q2 2017. 188 funds tracked by Wall St. Rank hold CHRS as of Q4 2019.

Partner Investment Management held 3,771 shares of Coherus Oncology worth $68K as of Q4 2019.
Partner Investment Management sold 4,035 Coherus Oncology shares in Q4 2019, an estimated $74.4K.
Coherus Oncology made up 0.49% of Partner Investment Management's portfolio in Q4 2019, its #39 holding.
Partner Investment Management first reported a position in Coherus Oncology in Q2 2015 and has held it in 9 quarters since.
Partner Investment Management's Coherus Oncology position peaked at $348K in Q2 2017.
188 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.